Last update :
19/11/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Vasodilator   Adenosin  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Adenis Venezuela
Adenocard Brazil, Canada, Chile, United States of America
Adenocil Peru
Adenocor Australia, Belgium, Colombia, Denmark, Finland, Great Britain, Greece, Hungary, India, Ireland, Italy, Luxembourg, Malaysia, Netherlands, New Zealand, Peru, Poland, Portugal, Republic of South Africa, Saudi Arabia, Spain, Sweden
Adenoject India
Adenoscan Australia, Germany, Great Britain, India, Ireland, Italy, Luxembourg, Portugal, Spain, Sweden, United States of America
Adenosin Austria, Denmark, Germany, Norway, Poland, Romania, Turkey
Adenosina Argentina, Chile, Peru
Adenosine Canada, Colombia, Great Britain, Iran, New Zealand
Adenotek Turkey
Adnet India
Adozin Turkey
Adrekar Germany
Atepodin Spain
Cadsine India
Cardimax Ecuador, Peru
Carnosin India
Carnosine India
Courina Mexico
Krenosin Iran, Italy, Mexico
Krenosine Switzerland
Pisdeno Chile, Mexico
Tachyban India
Tricor Chile
Stability in solutions   injection   Stability in solutions : Adenosin     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass None 3 mg/ml -15°C Protect from light
28 Day
816
Level of evidence A
Glass None 3 mg/ml 25°C Protect from light
7 Day
816
Level of evidence A
Glass None 3 mg/ml 5°C Protect from light
14 Day
816
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,05 mg/ml 2-8°C Not specified
14 Day
3223
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,05 mg/ml 23-25°C Not specified
14 Day
3223
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,1 mg/ml 2-8°C Not specified
14 Day
3223
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,1 mg/ml 23-25°C Not specified
14 Day
3223
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,22 mg/ml 2-8°C Not specified
14 Day
3223
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,22 mg/ml 23-25°C Not specified
14 Day
3223
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,75 mg/ml -15°C Protect from light
16 Day
816
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,75 mg/ml 25°C Protect from light
16 Day
816
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,75 mg/ml 5°C Protect from light
16 Day
816
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 2 mg/ml 2-8°C Not specified
14 Day
4070
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 2 mg/ml 20-25°C Not specified
14 Day
4070
Level of evidence A
Polyvinyl chloride Ringer’s lactate solution 0,75 mg/ml -15°C Protect from light
14 Day
816
Level of evidence A
Polyvinyl chloride Ringer’s lactate solution 0,75 mg/ml 25°C Protect from light
14 Day
816
Level of evidence A
Polyvinyl chloride Ringer’s lactate solution 0,75 mg/ml 5°C Protect from light
14 Day
816
Level of evidence A
Polypropylene Sodium chloride 0,9% 0,006 mg/ml 4°C Protect from light
180 Day
820
Level of evidence A
Polyolefine NaCl 0,9% or Glucose 5% 0,01 mg/ml 2-8°C Not specified
14 Day
3422
Level of evidence A
Polyolefine NaCl 0,9% or Glucose 5% 0,01 mg/ml 20-25°C Not specified
14 Day
3422
Level of evidence A
Polyolefine NaCl 0,9% or Glucose 5% 0,05 mg/ml 2-8°C Not specified
14 Day
3422
Level of evidence A
Polyolefine NaCl 0,9% or Glucose 5% 0,05 mg/ml 20-25°C Not specified
14 Day
3422
Level of evidence A
Polyolefine Sodium chloride 0,9% 2 mg/ml 2-8°C Not specified
14 Day
4070
Level of evidence A
Polyolefine Sodium chloride 0,9% 2 mg/ml 20-25°C Not specified
14 Day
4070
Level of evidence A
Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,75 mg/ml -15°C Protect from light
16 Day
816
Level of evidence A
Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,75 mg/ml 25°C Protect from light
16 Day
816
Level of evidence A
Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,75 mg/ml 5°C Protect from light
16 Day
816
Level of evidence A
Polypropylen Syringe Ringer’s lactate solution 0,75 mg/ml -15°C Protect from light
14 Day
816
Level of evidence A
Polypropylen Syringe Ringer’s lactate solution 0,75 mg/ml 25°C Protect from light
14 Day
816
Level of evidence A
Polypropylen Syringe Ringer’s lactate solution 0,75 mg/ml 5°C Protect from light
14 Day
816
Level of evidence A
Polypropylen Syringe None 3 mg/ml -15°C Protect from light
14 Day
816
Level of evidence A
Polypropylen Syringe None 3 mg/ml 25°C Protect from light
7 Day
816
Level of evidence A
Polypropylen Syringe None 3 mg/ml 5°C Protect from light
14 Day
816
Level of evidence A
Not specified Sodium chloride 0,9% 2 mg/ml 22°C Protect from light
180 Day
2216
Level of evidence B
Not specified Sodium chloride 0,9% 2 mg/ml 37°C Protect from light
180 Day
2216
Level of evidence B
Not specified Sodium chloride 0,9% 2 mg/ml 4°C Protect from light
180 Day
2216
Level of evidence B
  Mentions Légales